Image

Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)

Recruiting
18 - 60 years of age
Both
Phase 3

Powered by AI

Overview

The aim of this study is to assess the efficacy of stent implantation versus medical therapy on idiopathic intracranial hypertension with venous sinus stenosis.

Description

The SIMPLE is a multicentered, prospective, randomized, open-label, blinded end-point clinical trial. A total of 74 patients with idiopathic intracranial hypertension (IIH) and venous sinus stenosis (VSS) for more than 2 months will be enrolled. Patients fulfilling all of the inclusion criteria and none of the exclusion criteria will be randomized 1:1 into two groups (stenting or medical therapy) after offering informed content.

Eligibility

Inclusion Criteria:

  • Subject Eligibility Criteria
    1. Diagnosis of IIH by modified Dandy criteria for more than 2 months
    2. Lumbar puncture opening pressure ≥250 mmH₂O within 6 weeks before enrollment
    3. Normal cerebrospinal fluid (CSF) composition
    4. Neuroimaging showing normal brain parenchyma without hydrocephalus, mass, or any structural lesion and no evidence of meningeal enhancement on CT or MRI
    5. Localized venous sinus stenosis (VSS) with stenotic degree ≥ 50% on DSA, and pressure gradient across stenosis ≥ 8 mmHg
    6. Patients or their relatives signed written informed consent
  • Ophthalmic Eligibility Criteria:
    1. At least one eye had the presence of papilledema
    2. At least one eye of visual field loss: PMD ranging from - 2dB and below; decreased visual function on automated perimetry was reproducible with a false-positive rate of no more than 15%
    3. Visual acuity above 20 / 200 (≥ 39 letters)

Exclusion Criteria:

  • Subject Exclusion Criteria
    1. Previous surgery for IIH, including optic nerve sheath fenestration (ONSF), CSF shunting, decompressive craniectomy or venous sinus stenting
    2. Visual loss due to other etiologies (eg, retinal drusen, retinal and optic neuropathy, cataracts, etc)
    3. Other condition requiring the use of diuretics, steroids or other drugs to reduce intracranial pressure
    4. DSA showed diffused venous sinus stenosis, cortical or deep vein stenosis
    5. A history of severe thyroid disease and iodine allergy
    6. Pregnant or lactating women
    7. Severe cardiopulmonary, liver or kidney failure
    8. Known hereditary or acquired haemorrhagic diathesis
    9. Known hereditary or acquired thrombophilia
    10. Platelet counts or coagulation abnormality
    11. Major surgery or severe trauma or any traumatic brain injury within the previous 14 days
    12. A history of cerebral hemorrhage, arteriovenous malformation, intracranial aneurysm or tumor
    13. Other life threatening illness (eg, advanced cancer) likely to lead to death within a few months; the physical, psychological and social status of patients may affect follow-up (eg, drug addiction, advanced malignant disease, no telephone, no family, etc); cannot tolerate general anesthesia
    14. Increased intracranial pressure due to other secondary factors
  • Ophthalmic Exclusion Criteria:
    1. Current intraocular pressure > 28mmHg or previous intraocular pressure > 30mmHg
    2. Refractive error spherical power greater than -6.0D or +6.0D and astigmatism greater than 3.0D, except for the following cases:
      1. Myopia of - 6.0D to - 8.0D with the following: 1)There was no myopia related disease that can lead to decreased vision under the eyeground microscope (eg, scleral staphyloma, retinal thinning at the posterior pole, and moderate to severe disc tilt); 2) The patient wore contact lenses of appropriate degree for all visual field examinations.
      2. Hyperopia of +6.0D to +8.0D with the following: 1) The presence of a well characterized peri optic disc edematous halo, as opposed to crowded small optic discs or other features of decreased visual acuity associated with hyperopic changes, was at the discretion of the site investigator or reading center leader (or his designee); 2) The patient wore contact lenses of appropriate degree for all visual field examinations.
    3. Examination visible or past medical history known to have large optic disc drusen

      (persistent optic disc edema can present with small optic disc drusen, as low numbers are acceptable for inclusion and to be determined by the investigator to be unrelated to vision loss)

Study details

Idiopathic Intracranial Hypotension, Venous Sinus Stenosis

NCT05707442

Beijing Tiantan Hospital

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.